Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) displays sex-biased incidence, outcomes, molecular alterations and treatment efficacy; however, clinical managements are largely identical in male and female patients. Moreover, many biomarkers have been identified as predictors for ccRCC outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Huiyang, Qin, Xin, Yang, Qingya, Liu, Li, Fang, Zhiqing, Fan, Yidong, Xu, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334619/
https://www.ncbi.nlm.nih.gov/pubmed/37434223
http://dx.doi.org/10.1186/s13293-023-00526-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334619/
https://www.ncbi.nlm.nih.gov/pubmed/37434223
http://dx.doi.org/10.1186/s13293-023-00526-7

Ejemplares similares